Chronic Liver Disease Monitoring
You have a chronic liver disease, such as hepatitis B, hepatitis C, or fatty liver disease, and your doctor wants to track how fibrosis is progressing over time.
AI Summary FIB-4 and FIB-3 are blood-test scores that estimate liver scarring (fibrosis) without a biopsy, using your age, AST, platelet count, and, for FIB-4, ALT. A FIB-4 below 1.45 or FIB-3 below 1.3 suggests low risk; a FIB-4 above 3.25 or FIB-3 above 2.67 suggests advanced fibrosis. The scores don't measure fat or inflammation, so intermediate results often lead to FibroScan or imaging, and high results usually call for specialist evaluation.
Source: www.liverdirectory.com
Medically Reviewed.
The FIB-4 and FIB-3 scores are blood test calculations that estimate how much scarring, or fibrosis, has built up in your liver. Doctors use them most often for people with chronic liver disease, including hepatitis B, hepatitis C, and fatty liver disease (MASLD/MASH).
Neither score needs a procedure beyond a routine blood draw. FIB-4 combines your age, AST, ALT, and platelet count; FIB-3 combines your age, AST, and platelet count, leaving out ALT. Both give you a fast, low-risk way to check for fibrosis without a liver biopsy.
This page explains what each score measures, how to read your result, what a low, intermediate, or high score means for your next steps, and where FIB-3/FIB-4 fit alongside tests like FibroScan and liver biopsy.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
Fibrosis Score Basics
The FIB-4 (Fibrosis-4) and FIB-3 scores are blood test calculations that estimate how much scarring, or fibrosis, has built up in your liver. Both are used most often for people with chronic liver diseases such as hepatitis B, hepatitis C, or fatty liver disease (MASLD/MASH, sometimes called NAFLD/NASH).
Neither score requires a procedure beyond a routine blood draw. FIB-4 combines your age, AST, ALT, and platelet count; FIB-3 combines your age, AST, and platelet count, leaving out ALT. Because both come from routine labs, your doctor can repeat them over time to track how your liver disease is progressing or how well treatment is working, without the risks of a liver biopsy.
Blood-based tests like FIB-4 are recommended over no testing at all to help detect significant and advanced fibrosis.
Reasons for Testing
Your doctor may order a FIB-3 or FIB-4 score in several situations.
You have a chronic liver disease, such as hepatitis B, hepatitis C, or fatty liver disease, and your doctor wants to track how fibrosis is progressing over time.
You and your doctor want to avoid or delay a liver biopsy when a blood-based estimate can answer the question first.
Your doctor wants to determine your risk of advanced fibrosis or cirrhosis before deciding on further testing or treatment.
You are being treated for a liver condition and your doctor wants to see whether fibrosis is stable, improving, or getting worse.
Fibrosis Risk Ranges
Each score sorts your result into a low, intermediate, or high risk category for advanced liver fibrosis.
Combines age, AST, ALT, and platelet count.
< 1.45 low · 1.45–3.25 intermediate · > 3.25 high
Below 1.45: minimal or no significant liver fibrosis; usually no urgent intervention needed.
1.45–3.25: possible moderate fibrosis; may need further testing such as FibroScan or imaging.
Above 3.25: high likelihood of advanced fibrosis or cirrhosis; specialist evaluation and management recommended.
Combines age, AST, and platelet count (no ALT).
< 1.3 low · 1.3–2.67 intermediate · > 2.67 high
Below 1.3: minimal or no significant liver fibrosis; liver tissue generally healthy or only mildly affected.
1.3–2.67: possible moderate fibrosis; may require further testing or monitoring, such as FibroScan or imaging.
Above 2.67: high likelihood of advanced fibrosis or cirrhosis; specialist evaluation and management usually required.
The two scores correlate mathematically (FIB-3 = 2.69 × log(FIB-4) + 0.86), so they tend to move together, though they are not identical and your doctor may use one or both.
Score Formula Inputs
Both formulas use routine lab values plus your age — no new blood work beyond a standard panel.
Older age is linked with a higher risk of fibrosis, so both formulas weight age as a factor.
AST (aspartate aminotransferase) is a liver enzyme that rises with liver damage. Both FIB-4 and FIB-3 use your AST result.
ALT (alanine aminotransferase) is another liver enzyme that signals liver injury. FIB-4 includes it; FIB-3 does not.
Lower platelet counts can indicate more advanced liver disease. Both formulas factor in your platelet count.
Result Limits and Follow-Up
FIB-4 and FIB-3 only estimate fibrosis (scarring). They do not measure fat buildup (steatosis) or inflammation, so they cannot fully diagnose conditions like MASH on their own. Think of them as a starting point rather than a complete diagnostic test.
Blood-based scores like FIB-4 tend to be very good at ruling out advanced fibrosis — a low score has high accuracy for telling you that serious scarring is unlikely. They are less precise at confirming advanced fibrosis on their own, especially in people at lower overall risk, so a high score is usually followed by additional testing rather than treated as a final answer.
If your score falls in the intermediate range, or is high, your doctor will likely recommend a follow-up test such as FibroScan or another elastography-based imaging test, and in some cases a liver biopsy, to get a clearer picture of your liver.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
The difference is the number of lab values each formula uses. FIB-4 uses four: your age, AST, ALT, and platelet count. FIB-3 uses three: your age, AST, and platelet count, and it leaves out ALT. Each input tells the formula something about your liver. AST and ALT are liver enzymes that rise with liver damage. A lower platelet count can signal more advanced liver disease. Older age is linked with a higher risk of fibrosis. The two scores are linked by a formula (FIB-3 = 2.69 × log(FIB-4) + 0.86), so they tend to move together. Both sort your result into low, intermediate, and high risk for advanced fibrosis, but the cutoffs differ. For FIB-4 they are 1.45 and 3.25. For FIB-3 they are 1.3 and 2.67. Because the scales differ, compare each score only with its own cutoffs. Your doctor may use one score or both.
No. Both scores come from a routine blood draw plus your age. There is no imaging, biopsy, or other procedure. The lab values, AST, ALT, and platelet count, are part of standard blood work. Your doctor enters them into a formula to get the score. That makes the scores quick, safe, and convenient. Because the inputs are routine, your doctor can repeat the calculation over time. This helps track whether fibrosis is stable, improving, or getting worse. It also helps show how well treatment is working, and it can help you and your doctor avoid or delay a liver biopsy when a blood-based estimate can answer the question first.
A low score means it is unlikely you have significant liver fibrosis. A low score is a FIB-4 below 1.45 or a FIB-3 below 1.3. It usually points to liver tissue that is healthy or only mildly affected, and it generally does not call for urgent action. Blood-based scores like FIB-4 are especially good at ruling out advanced fibrosis. A low result is therefore reassuring about serious scarring. A low score is still only an estimate of scarring. It does not measure fat buildup or inflammation. Your doctor may still suggest ongoing monitoring, depending on your other risk factors and the liver condition you have.
An intermediate score means your result is not clearly low or clearly high risk. That range is 1.45 to 3.25 for FIB-4 and 1.3 to 2.67 for FIB-3. It means moderate fibrosis is possible, but the score alone cannot confirm it. Your doctor will likely recommend more testing to get a clearer picture. This is often FibroScan or another imaging test. Those results help your doctor decide on next steps, which may include monitoring, lifestyle changes, or treatment. An intermediate score is a reason to look further, not a diagnosis.
A high score suggests a high likelihood of advanced fibrosis or cirrhosis. That means a FIB-4 above 3.25 or a FIB-3 above 2.67. It does not confirm a diagnosis by itself. Blood-based scores are less precise at confirming advanced fibrosis than at ruling it out. This is especially true in people at lower overall risk. For that reason, a high score is usually followed by more testing rather than treated as a final answer. Your doctor will usually recommend specialist evaluation. They may also suggest elastography imaging such as FibroScan or, in some cases, a liver biopsy, to assess how severe your liver disease is.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.